banner9
Post a Comment Print Share on Facebook
Featured PYD PKK Coronavirus pandemic latest Foreign Minister Ertuğruloğlu met with Olson Indonesia tsunami Van Dijk
banner6

reads.

A new blood test could help target treatment for men with advanced prostate cancer

They found those with multiple copies of a particular gene did not respond to abiraterone and enzalutamide - drugs commonly used to treat advanced cases. More trials are needed but the team hope the test could prevent thousands of men undergoing unnecessary treatment and allow more personalised care. The drugs abiraterone and enzalutamide are given to men whose cancer is no longer responding to traditional hormone therapy and has started to spread. Costing less than £50, the test is a quick and relatively cheap way of preventing men from undergoing the side effects of therapy that will fail.

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.